BAX and colorectal cancer: The results of the present study suggest that NRAF may be useful for integrative and complementary medicine by promoting apoptotic cell death in HT-29 human colorectal cancer cells via induction of ROS production, GSH depletion, mitochondrial dysfunction, proapoptotic Bax protein modulation and caspase activation.